英科医疗 - Financials

英科医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	9.5B	6.9B	6.6B	16.2B	13.8B
Revenue Growth %	37.6%	4.6%	-59.3%	17.4%	--
Total Revenue	9.5B	6.9B	6.6B	16.2B	13.8B
Cost Of Revenue	7.3B	6.0B	5.7B	6.3B	4.3B
+Gross Profit	2.3B	948.0M	868.0M	10.0B	9.6B
Gross Margin %	23.6%	13.7%	13.1%	61.5%	69.0%
Total Operating Cost	8.2B	6.8B	6.1B	7.6B	5.5B
Selling Expenses	288.0M	252.0M	218.0M	384.0M	324.0M
Admin Expenses	518.0M	487.0M	407.0M	555.0M	249.0M
Rd Expenses	398.0M	283.0M	252.0M	365.0M	293.0M
Finance Expenses	-437.0M	-306.0M	-627.0M	-19.2M	265.0M
+Operating Income	1.7B	439.0M	707.0M	8.7B	8.4B
Operating Margin %	17.6%	6.3%	10.7%	53.5%	60.5%
Non Operating Income	2.5M	38.3M	24.7M	7.6M	7.7M
Non Operating Expenses	70.4M	34.5M	27.5M	47.6M	30.0M
Investment Income	63.2M	87.4M	83.3M	28.5M	4.7M
Fair Value Change Income	280.0M	176.0M	59.7M	32.7M	3.2M
Asset Disposal Income	224,400	213,400	2.4M	378,100	15,100
Asset Impairment Loss	109.0M	5.3M	44.0M	5.7M	1.4M
Other Income	58.4M	40.3M	34.3M	32.1M	13.7M
Income Before Tax	1.6B	443.0M	704.0M	8.6B	8.3B
Income Tax	117.0M	54.8M	65.1M	1.2B	1.3B
+Net Income	1.5B	388.0M	639.0M	7.5B	7.0B
Net Margin %	15.7%	5.6%	9.7%	46.0%	50.6%
Net Income Attributable	1.5B	383.0M	629.0M	7.4B	7.0B
Minority Interest	26.2M	5.1M	10.3M	33.4M	-2.5M
Eps Basic	2.26	0.58	0.95	11.33	14.65
Eps Diluted	2.26	0.58	0.95	11.00	13.57

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	12.0B	7.2B	5.0B	5.0B	5.0B
Trading Financial Assets	6.7B	5.2B	1.6B	3.3B	1.4B
Accounts Receivable	1.4B	922.0M	554.0M	775.0M	517.0M
Notes Receivable	50,300	--	--	--	--
Notes And Accounts Receivable	1.4B	922.0M	554.0M	775.0M	517.0M
Prepayments	204.0M	132.0M	184.0M	175.0M	506.0M
Inventory	1.3B	1.1B	1.0B	1.1B	847.0M
Total Current Assets	22.0B	15.6B	10.2B	10.8B	8.5B
Long Term Equity Investment	--	--	--	--	--
Fixed Assets	--	7.7B	7.2B	5.9B	2.7B
Fixed Assets Total	8.5B	7.7B	7.2B	5.9B	2.7B
Construction In Progress	--	1.5B	1.7B	2.3B	863.0M
Construction In Progress Total	1.3B	1.5B	1.7B	2.3B	863.0M
Intangible Assets	767.0M	567.0M	583.0M	630.0M	349.0M
Long Term Deferred Expenses	5.2M	1.8M	1.8M	2.9M	14.9M
Total Non Current Assets	12.7B	11.5B	11.2B	9.9B	4.4B
Total Assets	34.6B	27.1B	21.5B	20.6B	12.9B
Short Term Borrowings	12.7B	7.0B	1.5B	50.5M	22.2M
Accounts Payable	766.0M	767.0M	910.0M	1.2B	639.0M
Advance Receipts	--	--	3.1M	3.1M	4.2M
Contract Liabilities	272.0M	294.0M	298.0M	411.0M	913.0M
Total Current Liabilities	14.7B	8.6B	3.2B	2.1B	2.2B
Long Term Borrowings	165.0M	75.8M	49.0M	199.0M	109.0M
Total Non Current Liabilities	2.3B	2.2B	2.3B	2.4B	1.3B
Total Liabilities	16.9B	10.8B	5.4B	4.5B	3.5B
Paid In Capital	646.0M	656.0M	660.0M	550.0M	352.0M
Capital Reserve	1.1B	1.3B	1.3B	1.5B	1.6B
Surplus Reserve	249.0M	221.0M	205.0M	196.0M	145.0M
Retained Earnings	15.5B	14.2B	13.9B	13.7B	7.3B
Minority Equity	278.0M	266.0M	243.0M	252.0M	98.9M
Equity Attributable	17.4B	16.0B	15.8B	15.9B	9.3B
Total Equity	17.7B	16.3B	16.0B	16.1B	9.4B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	9.5B	6.6B	7.3B	16.2B	15.0B
Tax Refunds Received	610.0M	565.0M	836.0M	653.0M	248.0M
Total Operating Cash Inflow	10.5B	7.4B	8.3B	17.3B	15.3B
Cash Paid For Goods	7.2B	5.0B	5.6B	6.7B	5.4B
Cash Paid To Employees	1.1B	979.0M	836.0M	843.0M	503.0M
Taxes Paid	170.0M	237.0M	106.0M	318.0M	356.0M
Total Operating Cash Outflow	9.4B	6.9B	7.3B	8.6B	6.8B
Operating Cash Flow	1.1B	502.0M	1.1B	8.7B	8.6B
Total Investing Cash Inflow	7.3B	2.6B	3.1B	2.9B	860.0M
Total Investing Cash Outflow	11.1B	6.6B	4.9B	10.6B	4.9B
Investing Cash Flow	-3.9B	-4.0B	-1.9B	-7.7B	-4.0B
Cash From Borrowings	14.1B	7.9B	1.8B	560.0M	418.0M
Dividends And Interest Paid	338.0M	185.0M	457.0M	1.1B	163.0M
Debt Repayments	8.0B	2.3B	564.0M	436.0M	840.0M
Total Financing Cash Inflow	15.2B	7.9B	1.9B	680.0M	1.1B
Total Financing Cash Outflow	13.8B	4.9B	1.4B	1.5B	1.0B
Financing Cash Flow	1.4B	3.0B	549.0M	-833.0M	56.1M
Net Change In Cash	-1.3B	-397.0M	19.7M	74.8M	4.3B
Ending Cash Balance	3.3B	4.6B	5.0B	5.0B	4.9B
Capex	1.8B	1.4B	1.7B	5.4B	2.9B